Phase I Trial Evaluating the Pharmacokinetics of Single Ascending Oral Doses of IRL757 in Healthy Elderly Volunteers

NCT06699628 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Not Applicable as This is a Mass Balance/Pharmacokinetic Study Performed in Healthy Subjects
Apathy

Interventions

DRUG: IRL757

Sponsor

Integrative Research Laboratories AB